Sanford Health Roger Maris Cancer Center ( Site 0189) — Fargo, North Dakota

Sanford Health Roger Maris Cancer Center ( Site 0189) is a clinical research site located in Fargo, North Dakota, United States 58102.

Crixeo Clinical Trials Trust Score: 15/100 (FAILING). This profile has not yet been claimed by the site owner.

Sanford Health Roger Maris Cancer Center ( Site 0189) has participated in 6 clinical trials with 4 currently active.

Therapeutic areas: Diffuse Large B-Cell Lymphoma, Endometrial Cancer, Malignant Neoplasm.

Sponsors: Merck Sharp & Dohme LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Fargo

Browse all research sites in North Dakota · View every site in Fargo

Sponsor Feasibility Report

Trust Score: 15/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sanford Health Roger Maris Cancer Center ( Site 0189)?

Sanford Health Roger Maris Cancer Center ( Site 0189) has a Crixeo Trust Score of 15/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sanford Health Roger Maris Cancer Center ( Site 0189) conducted?

Sanford Health Roger Maris Cancer Center ( Site 0189) has 6 clinical trials on record, with 4 currently active. Their work covers Diffuse Large B-Cell Lymphoma, Endometrial Cancer, Malignant Neoplasm.

Is Sanford Health Roger Maris Cancer Center ( Site 0189) accredited by Crixeo Clinical Trials?

Sanford Health Roger Maris Cancer Center ( Site 0189) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sanford Health Roger Maris Cancer Center ( Site 0189)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.